Peer-reviewedCC BY-NC-NDProceedings of the National Academy of Sciences of the United States of America
Barry Bloom and the convergence of immunology, infectious disease, and public health.
- 1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
- 2Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461.
- 3Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287.
Abstract
In early 2026, the world lost Barry Bloom, a great advocate for public health, an extraordinarily accomplished immunologist, and a science advisor who helped refocus policy on controlling infectious diseases, including neglected diseases such as leprosy. Barry's career took him from a life of laboratory discovery where he was enormously influential in catalyzing the late 20th century shift from studying the immune response of simple molecules to pathogenic microbes. As Dean of Harvard T.H. Chan School of Public Health he had a profound influence on the growth of the institution and the careers of many who have continued his work.
Related
- Mapping the frontiers of genomic disease surveillance research in the ASEAN region: scientometric insights for precision public health and next-generation epidemic intelligence
- The microbiota: An exercise immunology perspective
- Senescence and tumor immunology: A multifaceted interplay of influence
- Messenger RNA vaccine platforms from molecular optimization to infectious disease and cancer immunotherapy: a narrative review.
- 106 Multiplex epitranscriptomic profiling reveals RNA modification signatures of immune activation and therapeutic response in cancer immunology
BibTeX
@article{fortune2026barry,
title = {{Barry Bloom and the convergence of immunology, infectious disease, and public health.}},
author = {Sarah M Fortune and William R Jacobs and Arturo Casadevall},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
year = {2026},
month = oct,
doi = {10.1073/pnas.2632686123},
url = {https://europepmc.org/article/MED/42842409},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Barry Bloom and the convergence of immunology, infectious disease, and public health.
AU - Sarah M Fortune
AU - William R Jacobs
AU - Arturo Casadevall
PY - 2026
DA - 2026/10/07
JO - Proceedings of the National Academy of Sciences of the United States of America
DO - 10.1073/pnas.2632686123
UR - https://europepmc.org/article/MED/42842409
AB - In early 2026, the world lost Barry Bloom, a great advocate for public health, an extraordinarily accomplished immunologist, and a science advisor who helped refocus policy on controlling infectious diseases, including neglected diseases such as leprosy. Barry's career took him from a life of laboratory discovery where he was enormously influential in catalyzing the late 20th century shift from studying the immune response of simple molecules to pathogenic microbes. As Dean of Harvard T.H. Chan School of Public Health he had a profound influence on the growth of the institution and the careers of many who have continued his work.
SN - 0027-8424
SN - 1091-6490
ER -